Cara Therapeutics | CARA - Lucro Bruto Sobre Vendas

Preço das Ações
2.92
Mudança Diária
0.02 0.77%
Mensal
-24.88%
Anual
-82.45%
Q2 Previsão
2.82




Lucro Bruto Sobre Vendas Alterar Data
Acadia Pharmaceuticals USD 257.76M 778K 2025-12
Assertio Holdings USD 22.24M 970K 2024-06
Cara Therapeutics USD 2.57M 1.11M 2025-03
Cassava Sciences USD -3.96M 1.16M 2025-09
Chugai Pharma JPY 258.74B 25.81B 2025-12
Cipla INR 41.64B 6.31B 2025-12
Clal Biotechnology ILS -857K 1.42M 2022-06
Compugen USD 63.8M 63.56M 2025-12
CSL USD 4.46B 2.71B 2025-12
Grifols EUR 766.49M 39.74M 2024-12
Halozyme Therapeutics USD 281.77M 2.41M 2025-09
J&J USD 16.6B 118M 2025-12
Neurocrine Biosciences USD 787.9M 7M 2025-12
Pacira USD 142.25M 11.34M 2025-12
Pfizer USD 3.54B 7.61B 2025-09
RedHill Biopharma USD 584K 0 2024-06
Supernus Pharmaceuticals USD 164.04M 15.23M 2025-12
Vanda Pharmaceuticals USD 50.6M 5.5M 2024-12